On October 6, 2025, CPS Technologies Corp. (NASDAQ: CPSH) announced that it intends to offer shares of its common stock in an underwritten public offering. The offering will be managed by Roth Capital Partners, which will act as the sole book‑running manager. The announcement was made via a GlobeNewswire press release.
CPS disclosed that the underwriters will have a 45‑day option to purchase up to an additional 15% of the shares offered on the same terms and conditions. The company also noted that a shelf registration statement on Form S‑3 (File No. 333‑282266) was filed with the SEC on September 20, 2024, and became effective on October 17, 2024. A preliminary prospectus supplement and accompanying prospectus will be filed with the SEC once the offering is finalized.
This financing event is material because it provides CPS with additional capital that can be deployed to fund product development, expand manufacturing capacity, and support strategic initiatives in high‑performance materials. The public offering also signals the company’s confidence in its growth trajectory and its readiness to access broader capital markets. Investors will be able to assess the potential dilution and the use of proceeds once the offering details are finalized.
CPS Technologies specializes in advanced metal‑matrix composites and hermetic packaging for applications ranging from electric vehicles to defense systems. The proceeds from the offering are expected to support the company’s expansion into new markets and the commercialization of emerging technologies such as fiber‑reinforced aluminum and radiation shielding. The announcement is subject to market and other conditions, and no assurance is given as to the size or timing of the offering.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.